PathCision Medicine, Inc.

CIK 1959064 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for PathCision Medicine, Inc..

Recent SEC filings

FiledFormAccession number
Feb 5, 2026D/A0001959064-26-000002
Feb 21, 2024D0001959064-24-000002
Dec 30, 2022D0001959064-22-000001